Insider Trading March 4, 2026

Invesco Mortgage Director Buys 1,000 Shares; Q4 2025 Revenue Beats While EPS Margins Miss

Director Robert Waldner acquires $8,446 of stock as IVR posts strong revenue surprise and a modest EPS shortfall for the fourth quarter of 2025

By Maya Rios IVR
Invesco Mortgage Director Buys 1,000 Shares; Q4 2025 Revenue Beats While EPS Margins Miss
IVR

Robert Waldner, a director at Invesco Mortgage Capital Inc. (NYSE: IVR), purchased 1,000 shares of the company on February 27, 2026, at $8.4463 per share for a total of $8,446, according to a Form 4 filing. The company reported fourth-quarter 2025 results showing EPS of $0.56 versus an expected $0.59, while revenue of $56.06 million substantially outpaced expectations of $36.43 million. InvestingPro analysis places the stock below its Fair Value and on its most undervalued list, noting a 17.2% dividend yield and a P/E of 6.39.

Key Points

  • Director Robert Waldner purchased 1,000 shares on Feb. 27, 2026, at $8.4463 per share, totaling $8,446, and now directly owns 1,000 shares.
  • InvestingPro analysis indicates IVR was trading at $8.36, below its Fair Value and listed among the platform’s most undervalued stocks; the company has a 17.2% dividend yield and a P/E of 6.39.
  • Fourth-quarter 2025 results were mixed: EPS of $0.56 missed the $0.59 estimate (a 5.08% shortfall), while revenue of $56.06 million exceeded expectations of $36.43 million (a 53.88% surprise).

Director Robert Waldner of Invesco Mortgage Capital Inc. (NYSE: IVR) filed a Form 4 disclosing the direct purchase of 1,000 shares of the company’s common stock on February 27, 2026. The transaction was executed at a per-share price of $8.4463, resulting in an aggregate purchase amount of $8,446. After the trade, Waldner is reported to directly own 1,000 shares of Invesco Mortgage Capital Inc.

The purchase occurred while IVR was trading at $8.36. According to InvestingPro analysis cited in company disclosures, that market price sits below the platform’s Fair Value estimate, and the stock appears on InvestingPro’s list of most undervalued names. The mortgage real estate investment trust carries a reported dividend yield of 17.2% and a price-to-earnings ratio of 6.39. InvestingPro Tips also note that the company has sustained dividend payments for 18 consecutive years. Additional detailed commentary, including five further ProTips and an expanded Pro Research Report, is available through the InvestingPro service.


Quarterly results

Invesco Mortgage Capital Inc.’s fourth-quarter 2025 financial results showed mixed outcomes versus consensus expectations. The company reported earnings per share (EPS) of $0.56, below the consensus figure of $0.59, representing a shortfall of 5.08%. In contrast, revenue for the quarter came in at $56.06 million, materially higher than the expected $36.43 million, a positive surprise of 53.88%.

The company’s earnings release did not include any commentary or updates regarding mergers or acquisitions. Additionally, there were no recent reports of analyst upgrades or downgrades from major firms disclosed alongside the results.


What the filings and results show

  • The Form 4 filing confirms a director-level insider purchase of 1,000 shares on February 27, 2026, at $8.4463 per share.
  • Market data referenced by InvestingPro places the stock below Fair Value at a trading price of $8.36 and highlights a high dividend yield and low P/E relative to the company’s profile.
  • Fourth-quarter 2025 results were mixed: EPS missed estimates by 5.08% while revenue beat by 53.88%.

These items together provide shareholders and market participants with a snapshot of recent insider activity and the company’s most recent operating results, without additional strategic announcements or analyst movement reported in the same disclosure set.

Risks

  • The company’s EPS missed consensus estimates for Q4 2025, introducing earnings-related uncertainty for investors - impacts equity and mortgage REIT sectors.
  • No updates on mergers or acquisitions were provided with the earnings release, leaving strategic direction and potential corporate actions unclear - impacts corporate strategy observers and investors.
  • There were no recent analyst upgrades or downgrades disclosed, which may limit fresh consensus guidance or re-evaluation by sell-side firms - impacts investor research and capital markets activity.

More from Insider Trading

Adaptive Biotechnologies President Rubinstein Disposes $769K in Shares, Exercises Options Mar 23, 2026 Director Ault Adds 24,000 Shares to Universal Safety Products Stake in Three Trades Mar 23, 2026 Sprouts VP Sells Shares to Cover Taxes as Analysts Trim Targets Mar 23, 2026 Sprouts CTO Sells 208 Shares to Cover RSU Taxes as Analysts Trim Targets After Q4 Beat Mar 23, 2026 Sprouts CFO Disposes $21,244 in Shares as Analysts Adjust Targets Mar 23, 2026